BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3308080)

  • 21. Phase II study of betaseron (beta ser17-interferon) as treatment of advanced malignant melanoma.
    Sarna GP; Figlin RA; Pertcheck M
    J Biol Response Mod; 1987 Aug; 6(4):375-8. PubMed ID: 3625229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase I study of recombinant beta-interferon given by four-hour infusion.
    Grunberg SM; Kempf RA; Venturi CL; Mitchell MS
    Cancer Res; 1987 Feb; 47(4):1174-8. PubMed ID: 3802098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beta=interferon in the treatment of 14 patients with advanced colorectal carcinoma.
    Pitini V; Palmara D; Ferraro G; Zanghi M; La Torre F; Tomasella R; Chille G
    J Exp Pathol; 1987; 3(4):603-5. PubMed ID: 3454807
    [No Abstract]   [Full Text] [Related]  

  • 24. Phase I study of recombinant methionyl human consensus interferon (r-metHuIFN-Con1).
    Neidhart JA; Schmidt S; Rosenblum M; Raber MN; Quesada JR; Alton NK; Downing M
    J Biol Response Mod; 1988 Jun; 7(3):240-8. PubMed ID: 3392552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant interferon alpha-2 (INTRON A) in a phase II study of renal cell carcinoma.
    Kempf RA; Grunberg SM; Daniels JR; Skinner DG; Venturi CL; Spiegel R; Neri R; Greiner JM; Rudnick S; Mitchell MS
    J Biol Response Mod; 1986 Feb; 5(1):27-35. PubMed ID: 3958753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
    Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A phase II study of 5-fluorouracil, leucovorin, and interferon-alpha in the treatment of patients with metastatic or recurrent gastric carcinoma: an Eastern Cooperative Oncology Group study (E5292).
    Hudes GR; Lipsitz S; Grem J; Morrisey M; Weiner L; Kugler JW; Benson A
    Cancer; 1999 Jan; 85(2):290-4. PubMed ID: 10023694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized phase II studies in advanced colorectal carcinoma: a North Central Cancer Treatment Group study.
    Windschitl H; Scott M; Schutt A; McCormack G; Everson L; Cullinan S; Gerstner J; Krook J; Laurie J; Shreck R
    Cancer Treat Rep; 1983 Nov; 67(11):1001-8. PubMed ID: 6640551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of metastatic colorectal carcinoma with lymphoblastoid interferon and 5-fluorouracil: data of a phase II study.
    Barzacchi MC; Nobile MT; Sanguineti O; Sertoli MR; Chiara S; Repetto L; Forno G; Lavarello A; Rosso R
    Anticancer Res; 1994; 14(5B):2147-9. PubMed ID: 7840514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase I/II trial of combined 131I anti-CEA monoclonal antibody and hyperthermia in patients with advanced colorectal adenocarcinoma.
    Mittal BB; Zimmer MA; Sathiaseelan V; Benson AB; Mittal RR; Dutta S; Rosen ST; Spies SM; Mettler JM; Groch MW
    Cancer; 1996 Nov; 78(9):1861-70. PubMed ID: 8909304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A phase I clinical trial of murine monoclonal antibody D612 in patients with metastatic gastrointestinal cancer.
    Saleh MN; Khazaeli MB; Grizzle WE; Wheeler RH; Lawson S; Liu T; Russel C; Meredith R; Schlom J; LoBuglio AF
    Cancer Res; 1993 Oct; 53(19):4555-62. PubMed ID: 8402627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Recombinant interferon alpha-2 (Sch 30500) in patients with head and neck cancer].
    Miyake H; Horiuchi M; Togawa K; Kawamoto K; Kaneko T; Inuyama Y; Honda Y; Baba S; Matsunaga T; Ishikawa T
    Gan To Kagaku Ryoho; 1985 Aug; 12(8):1651-5. PubMed ID: 3896156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Medical treatment of metastatic cancer of the kidney with a combination of vinblastine and recombinant interferon alpha IIa. Result of a phase I-II trial].
    Jacqmin D; Bergerat JP; Dufour P; Bollack C; Prévot G; Jurascheck F; Bailly G; Degaris S; Oberling F
    J Urol (Paris); 1987; 93(8):463-6. PubMed ID: 3440838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase I study of recombinant beta ser 17 interferon in the treatment of cancer.
    Sarna G; Pertcheck M; Figlin R; Ardalan B
    Cancer Treat Rep; 1986 Dec; 70(12):1365-72. PubMed ID: 3791249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Phase II trial of high-dose intravenous interferon alpha-2 in advanced colorectal cancer.
    Silgals RM; Ahlgren JD; Neefe JR; Rothman J; Rudnick S; Galicky FP; Schein PS
    Cancer; 1984 Nov; 54(10):2257-61. PubMed ID: 6488145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two randomised phase II trials of intermittent intravenous versus subcutaneous alpha-2 interferon alone (trial 1) and in combination with 5-fluorouracil (trial 2) in advanced colorectal cancer.
    Clark PI; Slevin ML; Reznek RH; Niederle N; Kurschel E; Lundell G; Cedermark B; Fallenius A; Blomgren H; Ohman U
    Int J Colorectal Dis; 1987 Feb; 2(1):26-9. PubMed ID: 3598328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant interferon beta: a phase I-II trial in children with recurrent brain tumors.
    Allen J; Packer R; Bleyer A; Zeltzer P; Prados M; Nirenberg A
    J Clin Oncol; 1991 May; 9(5):783-8. PubMed ID: 2016620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase II study of esorubicin in patients with advanced colorectal carcinoma and no prior chemotherapy: an Illinois Cancer Council Trial.
    Locker GY; Hoeltgen T; Kilton L; Krauss S; McNamara M; Blough R; Johnson C
    Cancer Treat Rep; 1987; 71(7-8):765-6. PubMed ID: 3300969
    [No Abstract]   [Full Text] [Related]  

  • 39. High dose rDNA human alpha 2 interferon therapy in patients with advanced colorectal adenocarcinoma: a phase II study.
    Lundell G; Blomgren H; Cedermark B; Silfverswärd C; Theve T; Ohman U
    Radiother Oncol; 1984 Mar; 1(4):325-32. PubMed ID: 6505269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and immunological evaluation of 20 patients with advanced colorectal cancer treated with high dose recombinant leukocyte interferon-alpha A (rIFN alpha A).
    Eggermont AM; Weimar W; Tank B; Dekkers-Bijma AM; Marquet RL; Lameris JS; Westbroek DL; Jeekel J
    Cancer Immunol Immunother; 1986; 21(1):81-4. PubMed ID: 3632919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.